 |
|
The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
Ji Won Lim, Su Jeong Ryu, Min Cheol Shin
Korean J Ophthalmol. 2010;24(3):155-158. Published online 2010 Jun 5 DOI: https://doi.org/10.3341/kjo.2010.24.3.155
|
|
Citations to this article as recorded by
 Comparing treatment outcomes in randomized controlled trials of central serous chorioretinopathy
John Thomas Goté, Sumit Randhir Singh, Jay Chhablani
Graefe's Archive for Clinical and Experimental Ophthalmology.2023; 261(8): 2135. CrossRef Central Serous Chorioretinopathy: An Update on the Current State of Management
Dimitrios Kalogeropoulos, Lincoln Shaw, Dimitra Skondra, Soon Wai Ch'ng, Aikaterini Christodoulou, Chris Kalogeropoulos
Klinische Monatsblätter für Augenheilkunde.2023;[Epub] CrossRef Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy
K Sandeep, Kavitha C Venugopal, Akshatha P Javagal, Pavana Acharya, S R Sreelekshmi, N Narendra, P K Nayana
Indian Journal of Ophthalmology.2023; 71(10): 3381. CrossRef Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome
David Xu, Elisha Garg, Kook Lee, Yoichi Sakurada, Atchara Amphornphruet, Nopasak Phasukkijwatana, Sandra Liakopoulos, Scott Eugene Pautler, Allan E Kreiger, Suzanne Yzer, Won Ki Lee, SriniVas Sadda, K Bailey Freund, David Sarraf
British Journal of Ophthalmology.2022; 106(4): 576. CrossRef Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment
Pushpinder Kanda, Arnav Gupta, Chloe Gottlieb, Rustum Karanjia, Stuart G. Coupland, Manpartap Singh Bal
Eye.2022; 36(5): 941. CrossRef Comparison of Retinochoroidal Vascular and Structural Changes after Half-Dose Photodynamic Therapy versus Half-Fluence Photodynamic Therapy Based on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy
Buğra Karasu, Yusuf Berk Akbas, Aslan Aykut, Ali Rıza Cenk Celebi
Ophthalmologica.2022; 245(4): 323. CrossRef Central serous chorioretinopathy: Treatment
JongBeom Park, Kiyoung Kim, MinSeok Kang, EungSuk Kim, Seung-Young Yu
Taiwan Journal of Ophthalmology.2022; 12(4): 394. CrossRef Actualización en el tratamiento de la coriorretinopatía serosa central crónica
F.J. Moreno-Morillo, J.I. Fernández-Vigo, N. Güemes-Villahoz, B. Burgos-Blasco, L. López-Guajardo, J. Donate-López
Archivos de la Sociedad Española de Oftalmología.2021; 96(5): 251. CrossRef Update on the management of chronic central serous chorioretinopathy
F.J. Moreno-Morillo, J.I. Fernández-Vigo, N. Güemes-Villahoz, B. Burgos-Blasco, L. López-Guajardo, J. Donate-López
Archivos de la Sociedad Española de Oftalmología (English Edition).2021; 96(5): 251. CrossRef Clinical course after the onset of choroidal neovascularization in eyes with central serous chorioretinopathy
Rae-Young Kim, Gun-Jung Ma, Woo-Kyung Park, Mirinae Kim, Young-Gun Park, Young-Hoon Park
Medicine.2021; 100(34): e26980. CrossRef Short-term effects of photodynamic therapy on segmentation of retinal layers in central serous chorioretinopathy
Shahram Agharokh, Mohammad-Reza Akhlaghi, Farzan Kianersi, Alireza Dehghani, Hamidreza Jahanbani-Ardakani, Seyed-Hossein Abtahi
Advanced Biomedical Research.2021; 10(1): 34. CrossRef Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review
Massimo Nicolò, Lorenzo Ferro Desideri, Aldo Vagge, Carlo Enrico Traverso
Pharmaceuticals.2020; 13(10): 264. CrossRef Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy
Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh, Sung Chul Lee, Demetrios G. Vavvas
PLOS ONE.2020; 15(9): e0238725. CrossRef TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY
Yoo-Ri Chung, Jong Wan Kim, Ji Hun Song, Aram Park, Min Ho Kim
Retina.2019; 39(1): 134. CrossRef Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy
Sibel Demirel, Gökçen Özcan, Özge Yanık, Figen Batıoğlu, Emin Özmert
Graefe's Archive for Clinical and Experimental Ophthalmology.2019; 257(5): 905. CrossRef Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years
Yang Jae Kim, Si Yeol Kim, Seungmin Ha, Daruchi Moon, San Seong, Oh Woong Kwon, Han Sang Park
Eye.2019; 33(5): 819. CrossRef Pharmacotherapy of Central Serous Chorioretinopathy: A Review of the Current Treatments
Pierluigi Iacono, Lisa Toto, Eliana Costanzo, Monica Varano, Maria Cristina Parravano
Current Pharmaceutical Design.2019; 24(41): 4864. CrossRef Central serous chorioretinopathy and glucocorticoids: an update on evidence for association
Benjamin P. Nicholson, Elizabeth Atchison, Amrou Ali Idris, Sophie J. Bakri
Survey of Ophthalmology.2018; 63(1): 1. CrossRef Treatment of Central Serous Chorioretinopathy (Csc) Using Diclofenac through Different Routes of Administration, a Comparative Study
Nisar Ahmed Khan
Advances in Ophthalmology & Visual System.2017;[Epub] CrossRef Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy
Brian E. Goldhagen, Raquel Goldhardt
Current Ophthalmology Reports.2017; 5(2): 141. CrossRef Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Andrzej Grzybowski
Graefe's Archive for Clinical and Experimental Ophthalmology.2017; 255(12): 2299. CrossRef Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis
Shangli Ji, Yemei Wei, Jiansu Chen, Shibo Tang
International Journal of Clinical Pharmacy.2017; 39(3): 514. CrossRef Topical Bromfenac in the Treatment of Central Serous Chorioretinopathy
Nisar Ahmed Khan
Advances in Ophthalmology & Visual System.2017;[Epub] CrossRef Exudative retinal detachment
Radgonde Amer, Hilal Nalcı, Nilüfer Yalçındağ
Survey of Ophthalmology.2017; 62(6): 723. CrossRef Efficacy of Intravitreal Bevacizumab for Recurrent Central Serous Chorioretinopathy in Patients Who Had Previously Responded Well to the Same Therapy
Kyung-Hoon Shin, Jae Hui Kim, Sung Won Cho, Tae Gon Lee, Chul Gu Kim, Jong Woo Kim
Journal of Ocular Pharmacology and Therapeutics.2016; 32(7): 425. CrossRef Bilateral Central Scotoma Due to CSCR in an Asthmatic Policeman
Lai Chan Fhun, Evelyn Tai Li Min, Mei Fong Chong, Ahmad Tajudin Liza-Sharmini
Open Journal of Ophthalmology.2016; 06(04): 240. CrossRef Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy
Emin Özmert, Sibel Demirel, Özge Yanık, Figen Batıoğlu
Journal of Ophthalmology.2016; 2016: 1. CrossRef Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis
H Q Lu, E Q Wang, T Zhang, Y X Chen
Eye.2016; 30(1): 15. CrossRef Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients
G A Kim, T H Rim, S C Lee, S H Byeon, H J Koh, S S Kim, C S Lee
Eye.2015; 29(6): 732. CrossRef Interventions for central serous chorioretinopathy: a network meta-analysis
Mahsa Salehi, Adam S Wenick, Hua Andrew Law, Jennifer R Evans, Peter Gehlbach
Cochrane Database of Systematic Reviews.2015;[Epub] CrossRef Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Alejandra Daruich, Alexandre Matet, Ali Dirani, Elodie Bousquet, Min Zhao, Nicolette Farman, Frédéric Jaisser, Francine Behar-Cohen
Progress in Retinal and Eye Research.2015; 48: 82. CrossRef A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study
John D Pitcher, Andre J Witkin, Francis Char DeCroos, Allen C Ho
British Journal of Ophthalmology.2015; 99(6): 848. CrossRef Therapeutic benefit of melatonin in refractory central serous chorioretinopathy
A L Gramajo, G E Marquez, V E Torres, C P Juárez, R E Rosenstein, J D Luna
Eye.2015; 29(8): 1036. CrossRef Cytokine levels of the aqueous humour in central serous chorioretinopathy
Sang Hoon Jung, Kyung‐a Kim, Sea Woon Sohn, Sung Jae Yang
Clinical and Experimental Optometry.2014; 97(3): 264. CrossRef Current concepts in managing central serous chorioretinopathy
Howard F. Fine, Michael D. Ober, Seenu M. Hariprasad
Ophthalmic Surgery, Lasers and Imaging Retina.2014; 45(1): 9. CrossRef Diagnosis and interventions for central serous chorioretinopathy: review and update
Godfrey Quin, Gerald Liew, I‐Van Ho, Mark Gillies, Samantha Fraser‐Bell
Clinical & Experimental Ophthalmology.2013; 41(2): 187. CrossRef Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review
Y-R Chung, E J Seo, H M Lew, K H Lee
Eye.2013; 27(12): 1339. CrossRef Central serous chorioretinopathy: a review of epidemiology and pathophysiology
Gerald Liew, Godfrey Quin, Mark Gillies, Samantha Fraser‐Bell
Clinical & Experimental Ophthalmology.2013; 41(2): 201. CrossRef The Efficacy of Intravitreal Bevacizumab for Acute Central Serous Chorioretinopathy
Erdinc Aydin
Journal of Ocular Pharmacology and Therapeutics.2013; 29(1): 10. CrossRef The stress response as a target for treatment of central serous chorioretinopathy
Dhiren Bujarborua, Shyamanga Borooah, Baljean Dhillon
Expert Review of Ophthalmology.2013; 8(5): 457. CrossRef Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment
Benjamin Nicholson, Jason Noble, Farzin Forooghian, Catherine Meyerle
Survey of Ophthalmology.2013; 58(2): 103. CrossRef Intravitreal Ranibizumab for Acute Central Serous Chorioretinopathy
Moosang Kim, Seung-Chan Lee, Seung-Jun Lee
Ophthalmologica.2013; 229(3): 152. CrossRef Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy
M J Koss, I Beger, F H Koch
Eye.2012; 26(2): 307. CrossRef Behandlung der Retinopathia centralis serosa
I. Beger, M.J. Koss, F. Koch
Der Ophthalmologe.2012; 109(12): 1224. CrossRef LOW-DOSE METHOTREXATE FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
Shree K. Kurup, Armando Oliver, Andres Emanuelli, Vincent Hau, David Callanan
Retina.2012; 32(10): 2096. CrossRef Review and update of central serous chorioretinopathy
Alexander Ross, Adam H Ross, Quresh Mohamed
Current Opinion in Ophthalmology.2011; 22(3): 166. CrossRef
|